Get startedLog in
    Picture of Adagene logo

    ADAG — Adagene News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Adagene Presents Clinical Data Demonstrating Strong Safety And Early Signals Of Efficacy In Treatment-Resistant Tumors For Anti-CTLA-4 Monoclonal Antibody, ADG116, At ESMO-IO 2021

    Picture of Adagene logoAdagene
    06/12/2021 12:38
    Dec 6 (Reuters) - Adagene Inc  978y.F :
    * ADAGENE PRESENTS CLINICAL DATA DEMONSTRATING STRONG SAFETY
AND
EARLY SIGNALS OF EFFICACY IN TREATMENT-RESISTANT TUMORS FOR
ANTI-CTLA-4 MONOCLONAL ANTIBODY, ADG116, AT ESMO-IO 2021

Source text for Eikon:  ID:nGNX2Zn3qN 
Further company coverage:  978y.F 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Adagene

    See all news